kodak ltek buy stake enzon ltenzn eastman kodak acquire 187 pct equity interest enzon inc pharmaceutical company specialize protein therapy kodak secure worldwide marketing right enzon peg enzyme treatment oxygen toxicity disorder hyperuricemia gout company acquire mln enzon share 15 mln dlrs loan enzon mln dlrs interest 30000 dlrs credit purchase price kodak drug cover marketing right initial stage us food drug administration approval process investment provide capital complete fda review process provide marketing outlet drug drug pegsuperoxide disdmutase pegcatalase oxygen toxicity disorder oftenfatal tissue damage severe burn organ transplant heart attack trauma peguricase treatment gout condition cause buildup high level uric acid body